The massive dilution (~45% of pre-deal shares outstanding) will pressure the stock. Watch for the closing on May 14 and any subsequent trading volume as the registration statement is filed. The insider participation and lock-up provide some near-term support, but the fundamental signal is a distressed capital raise. Consider short-term bearish positioning.
Price Chart
Executive Summary
Whitehawk Therapeutics announced an $87.5M PIPE financing, selling 4,330,866 shares at $3.92/share and 17,991,021 pre-funded warrants at $3.9199/warrant. The proceeds will extend the cash runway into H2 2028, but the massive dilution (~22.3M new shares vs. ~49.5M pre-deal) is severely bearish for existing shareholders. The $39.75M insider participation and 60-day lock-up provide some signal alignment, but the core event is a deeply dilutive capital raise at a ~$194M market cap.
Key Financial Metrics
Key Facts
- Total gross proceeds of $87.5 million from PIPE financing
- 4,330,866 shares of common stock sold at $3.92 per share
- 17,991,021 pre-funded warrants sold at $3.9199 per warrant, exercisable at $0.0001 per share
- Insiders (executives, directors, affiliated funds) committed $39.75 million of the total
- Proceeds expected to extend cash runway into second half of 2028
- 60-day lock-up agreements for executive officers and directors
- Closing expected May 14, 2026, subject to customary conditions
- Registration rights agreement to be filed within 30 days of closing
Financial Impact
$87.5 million gross proceeds; dilution of approximately 22.3 million new shares (common + warrant shares) against a pre-deal market cap of ~$194M
Risk Factors
- Severe dilution to existing shareholders from 22.3 million new shares
- Potential for further price decline as the market absorbs the offering
- Clinical-stage biotech with no approved products; cash burn continues
- Risk that the PIPE does not close if conditions are not met
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-220656 |
| Document: d854431dex102.htm | 0001193125-26-220656 |
| Document: d854431dex41.htm | 0001193125-26-220656 |
| Document: d854431d8k.htm | 0001193125-26-220656 |
| Document: d854431dex991.htm | 0001193125-26-220656 |
| Document: 0001193125-26-220656-index-headers.html | 0001193125-26-220656 |
| Document: 0001193125-26-220656-index.html | 0001193125-26-220656 |
| Document: 0001193125-26-220656.txt | 0001193125-26-220656 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 10, 2026 6w ago | 8-K | $4.11 $4.07 | ▼ −0.97% | ▼ −0.53% | $3.20 (−22.14%) |
Aug 6, 2026 11w ago | 8-K | $4.70 $4.76 | ▲ +1.28% | ▲ +0.67% | $3.20 (−31.91%) |
Jun 10, 2026 19w ago | EFFECT | $4.02 $4.06 | ▼ −0.99% | ▲ +0.70% | $3.20 (+20.40%) |
May 29, 2026 21w ago | S-3 | $4.49 $4.18 | ▲ +6.90% | ▲ +7.06% | $3.20 (+28.73%) |
May 13, 2026 23w ago | 8-K | $4.93 $5.10 | ▼ −3.45% | ▼ −2.67% | $3.20 (+35.09%) |
May 7, 2026 24w ago | 8-K | $3.94 $3.97 | ▲ +0.76% | ▼ −0.07% | $3.20 (−18.78%) |
Apr 8, 2026 28w ago | Insider Cluster | $3.55 $3.39 | ▲ +4.51% | ▲ +4.45% | $3.20 (+9.86%) |
Apr 8, 2026 28w ago | Insider Cluster | $3.55 $3.39 | ▲ +4.51% | ▲ +4.45% | $3.20 (+9.86%) |
Apr 8, 2026 28w ago | Insider Cluster | $3.55 $3.39 | ▲ +4.51% | ▲ +4.45% | $3.20 (+9.86%) |
Mar 12, 2026 32w ago | 8-K | $3.90 $3.91 | ▲ +0.26% | ▲ +0.85% | $3.20 (−17.95%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers